The Future of Pharmaceutical Contract Development and Manufacturing Market
According to MarketsandMarkets, the global pharmaceutical contract development and manufacturing market is projected to reach USD 126.63 billion by 2024 … Keep Reading
Pharmapack Europe unpacks key drivers and challenges in 2020
Pharmapack Europe (#pharmapackeu), organised by Informa Markets, has pinpointed a number of opportunities and threats that drug delivery and pharmaceutical packaging companies must address in 2020. The event, widely seen as Europe’s leading hub for the pharmaceutical packaging and drug delivery industry, will take place next week at the Porte De Versailles in Paris (5-6 February, 2020), with executives meeting to debate key trends, learn new insights and meet new partners. This year’s conference agenda provides a window into the…
You might be interested in
Eisai: Dayvigo (Lemborexant) Approved for Treatment of Insomnia in Japan
Eisai Co., Ltd. announced today that it has obtained the manufacturing and marketing approval in Japan for its in-house discovered orexin receptor antagonist DAYVIGO (2.5mg, 5mg, and 10mg tablets, lemborexant) for treatment of insomnia. DAYVIGO is a dual orexin receptor antagonist that inhibits orexin neurotransmission regulating sleep-wake rhythm by binding competitively to the two subtypes of orexin receptors (OX1R and OX2R). Blocking the binding of wake-promoting neuropeptides orexin to orexin receptors is thought to suppress wake drive by balancing sleep-wake…
Asia-Pacific has a Record Year for Clinical Trials, according to Novotech CRO
Novotech, the largest biotech CRO in Asia Pacific, says the region has had a record year for clinical trials in terms of the numbers of studies, experienced world-class sites and investigators, and patient enrollment. Novotech released its ‘Asia-Pacific Industry Highlights 2019-2020’ during the annual JP Morgan Healthcare Conference (Jan 7-10) in San Francisco, as part of its biotech industry briefing on the benefits of conducting clinical research in Asia-Pacific. The briefing covered:– Asia’s vast patient pools,– High-quality infrastructure,– Lower trial…
You might be interested in
